Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04668391
Other study ID # IRB-2020-350
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 17, 2020
Est. completion date July 2, 2021

Study information

Verified date June 2022
Source Zhejiang Cancer Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized, controlled, noninferiority trial for evaluating the efficacy of ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament versus thoracic epidural analgesia after open liver surgery.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date July 2, 2021
Est. primary completion date June 2, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age=18 years - ASA I-III - Open liver surgery Exclusion Criteria: - Contraindication to nerve block or epidural puncture - Chronic use of opioids or NSAIDs - Refused to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament
Bilateral single-injection 20 ml 0.56% ropivacaine. Intravenous analgesia was started postoperatively and consisted of 1ug/ml sufentanil,2 ml/h with a 5-minute lockout period, a limited 12 ml/h dose.
Thoracic epidural analgesia
A thoracic epidural at the level of T7-10. Epidural infusion was started postoperatively and consisted of sufentanil (0.6ug/mL) and ropivacaine(0.2%) at 3ml/h.

Locations

Country Name City State
China Zhejiang Cancer Hospital Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Zhejiang Cancer Hospital

Country where clinical trial is conducted

China, 

References & Publications (1)

Li H, Ma D, Liu Y, Wang Y. A transverse approach for ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament. Anaesthesia. 2020 Oct;75(10):1400-1401. doi: 10.1111/anae.15058. Epub 2020 Jun 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary NRS (numeric rating scale) score for coughing pain Postoperative pain was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain) at 24 hours after surgery
Secondary NRS score for rest and coughing pain Postoperative pain at rest and during coughing was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain) at 1, 6, 24, 48, 72 hours after surgery
Secondary consumption of opioid converted to IV morphine equivalents opioids given postoperatively converted to IV morphine equivalents during 24 hours after surgery
Secondary Numbers of additional analgesics Additional rescue analgesics were used when pain relief was inadequate (NRS >3). The choice of rescue analgesic was oxydone 5-10mg. during 72 hours after surgery
Secondary The incidence of postoperative hypotension Adverse reactions related to analgesia during 72 hours after surgery
Secondary The incidence of nausea and vomiting Adverse reactions related to analgesia during 72 hours after surgery
Secondary The incidence of pruritus Adverse reactions related to analgesia during 72 hours after surgery
Secondary The incidence of respiratory depression Adverse reactions related to analgesia during 72 hours after surgery
Secondary Time to ambulation in days Postoperative ambulation time through study completion, an average of 2-3 days
Secondary Time to eat in days Time to start eating after surgery through study completion, an average of 2-3 days
Secondary Time to flatus in hours Time to flatus after surgery through study completion, an average of 40-50 hours
Secondary Time to defecation in hours Time to defecation after surgery through study completion, an average of 60-70 hours
Secondary Time to urethral catheter removal in hours Time tourethral catheter removal after surgery through study completion, an average of 60-70 hours
Secondary Postoperative hospital stay in days The time from operation to discharge through study completion, an average of 7-8 days
Secondary Clavien-Dindo classification (grade I, II, III, IV) for postoperative complication Postoperative Clavien-Dindo complication classification One month after surgery
See also
  Status Clinical Trial Phase
Completed NCT04092608 - Restrictive vs Goal Directed Fluid Therapy During Hepatobiliary Surgery N/A
Completed NCT02993640 - Optimization of Hepatic Hemodynamics During Liver Surgery Early Phase 1
Completed NCT05116735 - Biliary Fistula and Late Recurrence of Liver Hydatid Cyst: Role of Cysto-biliary Communication N/A
Recruiting NCT03686137 - Institut Paoli Calmettes Hepatic Surgery Database
Recruiting NCT05594641 - Lactate Clearance After RIPC in Liver Resection N/A
Active, not recruiting NCT03270917 - ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection N/A
Completed NCT03793933 - ACS-NSQIP Calculator for Liver Surgery
Completed NCT01523353 - Prehabilitation in Liver Surgery Phase 1
Completed NCT00918619 - Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection Phase 4
Completed NCT02050841 - Octaplas Pediatric Plasma Replacement Trial Phase 4
Recruiting NCT01267786 - The Effect of Volatile Anesthetics Sevoflurane and Desflurane on Liver, Renal and Cardiovascular Systems During Liver Surgery Phase 4
Recruiting NCT02715427 - Enhanced Recovery After Hepatic Surgery (MultiPAS). N/A